212 related articles for article (PubMed ID: 35332326)
1. Chromatin domain alterations linked to 3D genome organization in a large cohort of schizophrenia and bipolar disorder brains.
Girdhar K; Hoffman GE; Bendl J; Rahman S; Dong P; Liao W; Hauberg ME; Sloofman L; Brown L; Devillers O; Kassim BS; Wiseman JR; Park R; Zharovsky E; Jacobov R; Flatow E; Kozlenkov A; Gilgenast T; Johnson JS; Couto L; Peters MA; Phillips-Cremins JE; Hahn CG; Gur RE; Tamminga CA; Lewis DA; Haroutunian V; ; Dracheva S; Lipska BK; Marenco S; Kundakovic M; Fullard JF; Jiang Y; Roussos P; Akbarian S
Nat Neurosci; 2022 Apr; 25(4):474-483. PubMed ID: 35332326
[TBL] [Abstract][Full Text] [Related]
2. Survey of schizophrenia and bipolar disorder candidate genes using chromatin immunoprecipitation and tiled microarrays (ChIP-chip).
Pedrosa E; Locker J; Lachman HM
J Neurogenet; 2009; 23(3):341-52. PubMed ID: 19225952
[TBL] [Abstract][Full Text] [Related]
3. Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.
Hu B; Won H; Mah W; Park RB; Kassim B; Spiess K; Kozlenkov A; Crowley CA; Pochareddy S; ; Li Y; Dracheva S; Sestan N; Akbarian S; Geschwind DH
Nat Commun; 2021 Jun; 12(1):3968. PubMed ID: 34172755
[TBL] [Abstract][Full Text] [Related]
4. Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder.
Kushima I; Nakatochi M; Aleksic B; Okada T; Kimura H; Kato H; Morikawa M; Inada T; Ishizuka K; Torii Y; Nakamura Y; Tanaka S; Imaeda M; Takahashi N; Yamamoto M; Iwamoto K; Nawa Y; Ogawa N; Iritani S; Hayashi Y; Lo T; Otgonbayar G; Furuta S; Iwata N; Ikeda M; Saito T; Ninomiya K; Okochi T; Hashimoto R; Yamamori H; Yasuda Y; Fujimoto M; Miura K; Itokawa M; Arai M; Miyashita M; Toriumi K; Ohi K; Shioiri T; Kitaichi K; Someya T; Watanabe Y; Egawa J; Takahashi T; Suzuki M; Sasaki T; Tochigi M; Nishimura F; Yamasue H; Kuwabara H; Wakuda T; Kato TA; Kanba S; Horikawa H; Usami M; Kodaira M; Watanabe K; Yoshikawa T; Toyota T; Yokoyama S; Munesue T; Kimura R; Funabiki Y; Kosaka H; Jung M; Kasai K; Ikegame T; Jinde S; Numata S; Kinoshita M; Kato T; Kakiuchi C; Yamakawa K; Suzuki T; Hashimoto N; Ishikawa S; Yamagata B; Nio S; Murai T; Son S; Kunii Y; Yabe H; Inagaki M; Goto YI; Okumura Y; Ito T; Arioka Y; Mori D; Ozaki N
Biol Psychiatry; 2022 Sep; 92(5):362-374. PubMed ID: 35667888
[TBL] [Abstract][Full Text] [Related]
5. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci.
Wiström ED; O'Connell KS; Karadag N; Bahrami S; Hindley GFL; Lin A; Cheng W; Steen NE; Shadrin A; Frei O; Djurovic S; Dale AM; Andreassen OA; Smeland OB
Addiction; 2022 Mar; 117(3):600-610. PubMed ID: 34472679
[TBL] [Abstract][Full Text] [Related]
8. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
[TBL] [Abstract][Full Text] [Related]
9. The genome in three dimensions: a new frontier in human brain research.
Mitchell AC; Bharadwaj R; Whittle C; Krueger W; Mirnics K; Hurd Y; Rasmussen T; Akbarian S
Biol Psychiatry; 2014 Jun; 75(12):961-9. PubMed ID: 23958183
[TBL] [Abstract][Full Text] [Related]
10. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.
Abdolmaleky HM; Gower AC; Wong CK; Cox JW; Zhang X; Thiagalingam A; Shafa R; Sivaraman V; Zhou JR; Thiagalingam S
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):138-149. PubMed ID: 30468562
[TBL] [Abstract][Full Text] [Related]
11. Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder.
Corponi F; Bonassi S; Vieta E; Albani D; Frustaci A; Ducci G; Landi S; Boccia S; Serretti A; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():23-29. PubMed ID: 30149091
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
Smeland OB; Bahrami S; Frei O; Shadrin A; O'Connell K; Savage J; Watanabe K; Krull F; Bettella F; Steen NE; Ueland T; Posthuma D; Djurovic S; Dale AM; Andreassen OA
Mol Psychiatry; 2020 Apr; 25(4):844-853. PubMed ID: 30610197
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
Li Z; Li D; Chen X
J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression.
Holen B; Shadrin AA; Icick R; Filiz TT; Hindley G; Rødevand L; O'Connell KS; Hagen E; Frei O; Bahrami S; Cheng W; Parker N; Tesfaye M; Jahołkowski P; Karadag N; Dale AM; Djurovic S; Smeland OB; Andreassen OA
Addict Biol; 2023 Jun; 28(6):e13282. PubMed ID: 37252880
[TBL] [Abstract][Full Text] [Related]
15. Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits.
So HC; Chau KL; Ao FK; Mo CH; Sham PC
Psychol Med; 2019 Jun; 49(8):1286-1298. PubMed ID: 30045777
[TBL] [Abstract][Full Text] [Related]
16. Neural Correlates of the Risk for Schizophrenia and Bipolar Disorder: A Meta-analysis of Structural and Functional Neuroimaging Studies.
Cattarinussi G; Kubera KM; Hirjak D; Wolf RC; Sambataro F
Biol Psychiatry; 2022 Sep; 92(5):375-384. PubMed ID: 35523593
[TBL] [Abstract][Full Text] [Related]
17. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
[TBL] [Abstract][Full Text] [Related]
18. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
Bergen SE; O'Dushlaine CT; Ripke S; Lee PH; Ruderfer DM; Akterin S; Moran JL; Chambert KD; Handsaker RE; Backlund L; Ösby U; McCarroll S; Landen M; Scolnick EM; Magnusson PK; Lichtenstein P; Hultman CM; Purcell SM; Sklar P; Sullivan PF
Mol Psychiatry; 2012 Sep; 17(9):880-6. PubMed ID: 22688191
[TBL] [Abstract][Full Text] [Related]
20. Associated Genetics and Connectomic Circuitry in Schizophrenia and Bipolar Disorder.
Wei Y; de Lange SC; Savage JE; Tissink E; Qi T; Repple J; Gruber M; Kircher T; Dannlowski U; Posthuma D; van den Heuvel MP
Biol Psychiatry; 2023 Jul; 94(2):174-183. PubMed ID: 36803976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
